Seglentis® (celecoxib/tramadol) – New drug approval
October 18, 2021 - Esteve Pharmaceuticals announced the FDA approval of Seglentis (celecoxib/tramadol), for the management of acute pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Top